Published in J Mol Biol on April 05, 1993
Functional reconstitution of human FcRn in Madin-Darby canine kidney cells requires co-expressed human beta 2-microglobulin. J Biol Chem (2002) 1.58
Neonatal Fc receptor and IgG-based therapeutics. MAbs (2011) 1.56
Neonatal Fc receptor: from immunity to therapeutics. J Clin Immunol (2010) 1.50
Ligand valency affects transcytosis, recycling and intracellular trafficking mediated by the neonatal Fc receptor. Traffic (2006) 1.36
Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics. Crit Rev Biotechnol (2013) 1.31
Design and expression of a dimeric form of human immunodeficiency virus type 1 antibody 2G12 with increased neutralization potency. J Virol (2008) 1.11
The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity. MAbs (2015) 1.10
The immunologic functions of the neonatal Fc receptor for IgG. J Clin Immunol (2012) 1.06
Soluble monomeric IgG1 Fc. J Biol Chem (2012) 1.06
Ca2+-dependent calmodulin binding to FcRn affects immunoglobulin G transport in the transcytotic pathway. Mol Biol Cell (2007) 0.99
Analytical FcRn affinity chromatography for functional characterization of monoclonal antibodies. MAbs (2013) 0.98
A freeze substitution fixation-based gold enlarging technique for EM studies of endocytosed Nanogold-labeled molecules. J Struct Biol (2007) 0.96
Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics. Proc Natl Acad Sci U S A (2015) 0.94
Effects of receptor dimerization on the interaction between the class I major histocompatibility complex-related Fc receptor and IgG. Proc Natl Acad Sci U S A (1995) 0.92
Regulation of immune responses by the neonatal fc receptor and its therapeutic implications. Front Immunol (2015) 0.85
Structural basis for enhanced HIV-1 neutralization by a dimeric immunoglobulin G form of the glycan-recognizing antibody 2G12. Cell Rep (2013) 0.84
A novel approach to investigate the effect of methionine oxidation on pharmacokinetic properties of therapeutic antibodies. MAbs (2014) 0.81
Hydrodynamic studies of a complex between the Fc fragment of human IgE and a soluble fragment of the Fc epsilon RI alpha chain. Proc Natl Acad Sci U S A (1995) 0.81
How the controller is controlled - neonatal Fc receptor expression and immunoglobulin G homeostasis. Immunology (2006) 0.81
Nanogold as a specific marker for electron cryotomography. Microsc Microanal (2009) 0.78
Impact of SPR biosensor assay configuration on antibody: Neonatal Fc receptor binding data. MAbs (2016) 0.77
Mechanism of increased clearance of glycated albumin by proximal tubule cells. Am J Physiol Renal Physiol (2016) 0.75
Advances in Therapeutic Fc Engineering - Modulation of IgG-Associated Effector Functions and Serum Half-life. Front Immunol (2016) 0.75
Characterization of the interactions of rabbit neonatal Fc receptor (FcRn) with rabbit and human IgG isotypes. PLoS One (2017) 0.75
T-cell antigen receptor genes and T-cell recognition. Nature (1988) 16.77
A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature (1988) 5.99
Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol (1991) 4.44
Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature (1989) 4.34
The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A (1998) 3.23
Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature (1994) 2.85
IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J (2001) 2.84
Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell (1998) 2.80
Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding. Mol Cell (2001) 2.67
Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol Cell (1999) 2.42
Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity (1999) 2.18
Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor. Nature (1994) 2.15
Crystal structure of invasin: a bacterial integrin-binding protein. Science (1999) 2.14
Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor. Nature (2000) 2.14
The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity (1999) 2.04
Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. Biochemistry (1995) 1.87
Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor(,). Biochemistry (2000) 1.87
Climate change and the integrity of science. Science (2010) 1.80
Fc receptors and their interactions with immunoglobulins. Annu Rev Cell Dev Biol (1996) 1.79
Generation of a humanized, high affinity anti-tissue factor antibody for use as a novel antithrombotic therapeutic. Thromb Haemost (2001) 1.64
Crystal structure of hemolin: a horseshoe shape with implications for homophilic adhesion. Science (1998) 1.59
Thermal stability comparison of purified empty and peptide-filled forms of a class I MHC molecule. Science (1992) 1.55
Structure of the human class I histocompatibility antigen, HLA-A2. J Immunol (2005) 1.52
Crystal structure of tandem type III fibronectin domains from Drosophila neuroglian at 2.0 A. Neuron (1994) 1.46
Expression and crystallization of a soluble and functional form of an Fc receptor related to class I histocompatibility molecules. Proc Natl Acad Sci U S A (1992) 1.44
High level Escherichia coli expression and production of a bivalent humanized antibody fragment. Biotechnology (N Y) (1992) 1.43
Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med (1998) 1.43
Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60. Immunity (2001) 1.43
Mutational analysis of the transferrin receptor reveals overlapping HFE and transferrin binding sites. J Mol Biol (2001) 1.41
Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE. J Biol Chem (2000) 1.41
Investigation of the interaction between the class I MHC-related Fc receptor and its immunoglobulin G ligand. Immunity (1994) 1.40
Crystal structure of the cysteine-rich domain of mannose receptor complexed with a sulfated carbohydrate ligand. J Exp Med (2000) 1.38
A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL. Biochemistry (2000) 1.34
Characterization of the 2:1 complex between the class I MHC-related Fc receptor and its Fc ligand in solution. Biochemistry (1999) 1.31
Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). Immunity (2000) 1.28
The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor. J Mol Biol (1999) 1.27
Retracted Binding to the transferrin receptor is required for endocytosis of HFE and regulation of iron homeostasis. Nat Cell Biol (2000) 1.26
Structural basis of pH-dependent antibody binding by the neonatal Fc receptor. Structure (1998) 1.25
The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity (1995) 1.20
Crystallization and X-ray diffraction studies on the histocompatibility antigens HLA-A2 and HLA-A28 from human cell membranes. J Mol Biol (1985) 1.18
The class I major histocompatibility complex related Fc receptor shows pH-dependent stability differences correlating with immunoglobulin binding and release. Biochemistry (1993) 1.18
Stoichiometry of the interaction between the major histocompatibility complex-related Fc receptor and its Fc ligand. Biochemistry (1999) 1.16
The transferrin receptor binding site on HFE, the class I MHC-related protein mutated in hereditary hemochromatosis. J Mol Biol (1999) 1.15
Crystal structure of the ectodomain of Methuselah, a Drosophila G protein-coupled receptor associated with extended lifespan. Proc Natl Acad Sci U S A (2001) 1.15
Identification of critical IgG binding epitopes on the neonatal Fc receptor. J Mol Biol (1997) 1.15
Characterization of the interaction between the herpes simplex virus type I Fc receptor and immunoglobulin G. J Biol Chem (1999) 1.14
In vivo calcineurin crystals formed using the baculovirus expression system. Microsc Res Tech (1996) 1.13
Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog. J Virol (1998) 1.13
Solution structure of the E-domain of staphylococcal protein A. Biochemistry (1996) 1.12
The (Greek) key to structures of neural adhesion molecules. Neuron (1996) 1.12
High-affinity binding of the neonatal Fc receptor to its IgG ligand requires receptor immobilization. Biochemistry (1997) 1.10
Structure of the extracellular domain of human tissue factor: location of the factor VIIa binding site. Biochemistry (1994) 1.08
Unusual MHC-like molecules: CD1, Fc receptor, the hemochromatosis gene product, and viral homologs. Curr Opin Immunol (1998) 1.06
Equilibrium and kinetic measurements of the conformational transition of reduced thioredoxin. Biochemistry (1987) 1.05
Structural and mutational analysis of affinity-inert contact residues at the growth hormone-receptor interface. Biochemistry (1996) 1.04
Enzymatic cleavage of a CD4 immunoadhesin generates crystallizable, biologically active Fd-like fragments. Biochemistry (1990) 1.02
Hinge bending within the cytokine receptor superfamily revealed by the 2.4 A crystal structure of the extracellular domain of rabbit tissue factor. Protein Sci (1998) 1.00
The tissue factor region that interacts with substrates factor IX and Factor X. Biochemistry (2000) 0.99
Interleukin 3 promotes histamine synthesis in hematopoietic progenitors by increasing histidine decarboxylase mRNA expression. Biochem Biophys Res Commun (1993) 0.98
Antibody variable region binding by Staphylococcal protein A: thermodynamic analysis and location of the Fv binding site on E-domain. Protein Sci (1999) 0.97
The 1.85 A resolution crystal structures of tissue factor in complex with humanized Fab D3h44 and of free humanized Fab D3h44: revisiting the solvation of antigen combining sites. J Mol Biol (2001) 0.97
Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. J Pharm Sci (1998) 0.97
Fab assembly and enrichment in a monovalent phage display system. Biotechnology (N Y) (1991) 0.96
Conformational transitions of thioredoxin in guanidine hydrochloride. Biochemistry (1984) 0.95
Effects of peptide length and composition on binding to an empty class I MHC heterodimer. Biochemistry (1994) 0.95
Generation of monoclonal antibodies against soluble human T cell receptor polypeptides. Eur J Immunol (1991) 0.94
Studies on the zinc binding site to the serum thymic factor. Biochim Biophys Acta (1984) 0.93
Extended repertoire of permissible peptide ligands for HLA-B*2702. Protein Sci (1996) 0.93
Effects of receptor dimerization on the interaction between the class I major histocompatibility complex-related Fc receptor and IgG. Proc Natl Acad Sci U S A (1995) 0.92
Hydrophobic ligand binding by Zn-alpha 2-glycoprotein, a soluble fat-depleting factor related to major histocompatibility complex proteins. J Biol Chem (2001) 0.92
BIAcore: a microchip-based system for analyzing the formation of macromolecular complexes. Structure (1995) 0.92
Silver enhancement of Nanogold particles during freeze substitution for electron microscopy. J Microsc (2008) 0.91
Biochemical characterization and crystalization of human Zn-alpha2-glycoprotein, a soluble class I major histocompatibility complex homolog. Proc Natl Acad Sci U S A (1997) 0.90
The tissue factor region that interacts with factor Xa in the activation of factor VII. Biochemistry (2001) 0.90
Molecular genetics of the chicken MHC: current status and evolutionary aspects. Immunol Rev (1990) 0.89
Epitope location on tissue factor determines the anticoagulant potency of monoclonal anti-tissue factor antibodies. Thromb Haemost (2000) 0.89
Thymic dysfunction in the mutant diabetic (db/db) mouse. J Immunol (1983) 0.89
Peptide interaction with a class I major histocompatibility complex-encoded molecule: allosteric control of the ternary complex stability. Biochemistry (1996) 0.89
Purification and characterization of tissue plasminogen activator kringle-2 domain expressed in Escherichia coli. Biochemistry (1989) 0.88
Effects of guanidine hydrochloride on the refolding kinetics of denatured thioredoxin. Biochemistry (1986) 0.87
Circular dichroism determination of class I MHC-peptide equilibrium dissociation constants. Protein Sci (1997) 0.87
Crystal structure of the kringle 2 domain of tissue plasminogen activator at 2.4-A resolution. Biochemistry (1992) 0.86
High affinity binding sites on plasma membrane obtained from the lymphoblastoid cultured 1301 cell line for highly radioactive serum thymic factor. Biochim Biophys Acta (1982) 0.86
Quantitative proteomic analysis of cyclosporine-induced toxicity in a human kidney cell line and comparison with tacrolimus. J Proteomics (2011) 0.85
Identification of a GDP-L-fucose:polypeptide fucosyltransferase and enzymatic addition of O-linked fucose to EGF domains. Glycobiology (1996) 0.84
The molecular mechanism of sulfated carbohydrate recognition by the cysteine-rich domain of mannose receptor. J Mol Biol (2001) 0.84
Expression and circular dichroism studies of the extracellular domain of the alpha subunit of the nicotinic acetylcholine receptor. J Biol Chem (1997) 0.84
Ligand binding to the tissue-type plasminogen activator kringle 2 domain: structural characterization by 1H-NMR. Biochemistry (1995) 0.83
Structural insights into antibody-mediated mucosal immunity. Curr Top Microbiol Immunol (2006) 0.83
Mutations in the D strand of the human CD4 V1 domain affect CD4 interactions with the human immunodeficiency virus envelope glycoprotein gp120 and HLA class II antigens similarly. Proc Natl Acad Sci U S A (1991) 0.82
Construction, expression, and purification of recombinant kringle 1 of human plasminogen and analysis of its interaction with omega-amino acids. Biochemistry (1991) 0.82
Factor VIIa's first epidermal growth factor-like domain's role in catalytic activity. Biochemistry (1999) 0.82
The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII. Biochemistry (1999) 0.81
A model for T cell receptor and MHC/peptide interaction. Adv Exp Med Biol (1989) 0.80
Comparison of orthorhombic and monoclinic crystal structures of HLA-A2. Cold Spring Harb Symp Quant Biol (1989) 0.80